# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-11 | **更新时间**: 07:05 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[21:00]` **Kincell Bio 宣布与 RegCell 合作，将 Treg 细胞疗法推进自身免疫性疾病的临床试验**
  <br><small>🇬🇧 *Kincell Bio Announces Partnership with RegCell to Advance Treg Cell Therapies into Clinical Trials for Autoimmune Diseases* [🔗Source](https://news.google.com/rss/articles/CBMiiwJBVV95cUxPQkR4cjVPT29vbkNleFJVUTlLX3BVU0tkLW8zbXlSSElaMDM3LW1acjZpU3NrSEVRNjN3bVdPb19QV2ZxOE1ZSlU5eHgwNjNCblVnb3Y4aEEyd1BaNHRPR3U1RXk0QW1zMmVFWmlLV3RUTmw5R0VUMmQyQ2J6cGszanlkblRzX29YdlYya0J0OVhnTkMya1MyT3c4b2xoSEUzR20xaUtlS2xXSXNXWnQybUNQdGdTLVIyNVo2akpTazlmMUNvWkVnbUJ0TDFwMFhhSUd1VTdKT01iZGRNY1NsNld0MzVtQ2NqTG1oWXlkNC12b3B2LXExUzBrV3NvOHFJdFBic1FpaU50TkU?oc=5)</small>
- `[21:00]` **Coya Therapeutics 将与顶尖医学专家举办网络研讨会，讨论肌萎缩侧索硬化症 (ALS) 药物开发、患者情况和正在进行的临床试验**
  <br><small>🇬🇧 *Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial* [🔗Source](https://news.google.com/rss/articles/CBMivwJBVV95cUxPaHlrOUlUYlA1RlRDZk5QS0JhWFNXVzNqWWV2ckRyVW5kakc2NFlMekRhYVV1d0hVaV9CZWdSMU8zZVVnS2NmT0hJQkVMQXJxa0tqbVZONUFJVjZTMWlGWXNmQmhNMXM1NkdGWE9SN1owNFFibEI2c3Y0WGdwWXp0Q25tSVNwWEg5UW15NkJZY1JESS1KQV9DYmJLUzI5ZVpsX1owYjFxSjBBNUdFMjBWbXBrTkxUYkxfb0pDc3pYOWo5VmZCa2ljWDQ3VF8zQS1UTTkwMFBrdjFvWjRSd0U0STBZRC1NU2ZjVFVwVFlXVmdaN2I1NlRqaTRqcGVwS2htWV9tSWZJT01ZbnlRUXhaUHQtcEFOUm40SG15Z2h3ejZBM2lGN1BYbjhkRHMzcGNJdzRpa3lyekkwRUJwX1pJ?oc=5)</small>
- `[19:00]` **Gyala Therapeutics 启动 CAR-T 细胞疗法治疗治疗选择有限的急性白血病的 I/IIa 期临床试验**
  <br><small>🇬🇧 *Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy in acute leukemias with limited treatment options* [🔗Source](https://news.google.com/rss/articles/CBMikgJBVV95cUxQVVN1NkszVDJvVUY1YXoyWnloamtVWTNfamJ5OFoxaVZzcHc3aWdaT0RlOVJuV0puUlljdkVlMWJHaXl0LUtKbkI3cWxDV1BxQklHYTVuOXdiWDU0R1BTWjdUclBwX3NJRWRuV2lMVHFSXzNBLXg3THpxR3h5N3pfVXE5YzM0cjNlakJTb3B2Tlo4NThfMXRkeUlqUFhnM2h2UktTelBSS2N4YTVuOGRVN3RPci1nUHNrZ0NxMzFRUEFWYjhHUlpoQmtTaVUwMmltM01COFVWb2xlcVJoVHNsQ2tSbjg1aC1kT3U5YkVZRy1qX3A3SzFCTXZjb1hwWjNVcUpWVG1wVW5oZ0JGdmZXUFR3?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[21:00]` **全球首个！这一“成都造”创新药进入临床阶段** [🔗阅读原文](https://news.google.com/rss/articles/CBMihwFBVV95cUxNN2llWEdLZHlJZEtJZFBfbVRrN2FjRUpmTmRwbmUzQXZrdVp6UGxnRkR5RGJtZlVWYURsanZsb3pOXzBMWkNTN21MdEgtdlBjdlFsdVQxSUVlYnNHbjRtNERwNWhNWVBiQURJTzdxNThEeHE5ZDQ3MFN2UGF4bXVVOGRVaWRxZzA?oc=5)
- `[17:42]` **【行业动态】礼来24亿美元收购Orna Therapeutics，强势进军体内CAR-T赛道** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE1ucXBHUzVmbTNTeXhsclk2dEpwaS1wNGszMEExU2djUjgtSEZvdEFJeXVUX1Z6NDdWVGxzQnBIVW9qa19vYk4zU0Z2eGw5eWt0Q0htZURNQUlTWF95OWpxT1NjZ1FuS3dCMi1Pd3ZkQmRsODA3Ukk1ZnZhWHFPUQ?oc=5)
- `[15:18]` **CAR-T细胞疗法治疗AML的当前挑战与未来方向** [🔗阅读原文](https://news.google.com/rss/articles/CBMiVkFVX3lxTE1Xek5GV1N6X2VxSk84bVVnMFdBOEJ4V1lSbFlJdTBFQmJoVTR2blJvSVV4NWR3S05FSmJXVGNzcExPWXFTc3oyUXcyTXFBaVRfbENpR1hR?oc=5)
- `[14:57]` **细胞治疗破局自身免疫病，通用型CAR-T展现治愈曙光| 徐沪济教授专访-MedSci.cn** [🔗阅读原文](https://news.google.com/rss/articles/CBMibkFVX3lxTE9xUGxDLVpYclVaOGV5Q3JGTmVza1E2bzdrVWt2aF8zcE9sQ3RIRnRIdks2YzRJQklzZ0lpaXFiWW9UN1kyS01rdG04M2JmdkJnMFcwdFU3b0REZTdPOG5xN2xYVzkwWUZCXzQ1QXRB?oc=5)
- `[14:29]` **交易频频！礼来24亿美元收购一体内CAR-T领域新秀** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE5PWXkxNTRUMTQ4Z1BCRzdiMkdFbTdsdk1CQTMzLXZQaWNrc0RFVFYxV3VQTWdQd04wRzZOcVRxbWJ1dFlyc1BDSVZaMzdvTm5YbmNOMVlueGc0YmVzUDBud3FLNENVRDVrYnFfNmMtT1dTVkRnV0FvVlIxb2pndw?oc=5)
- `[13:07]` **礼来2025年财报全景：营收飙升，市值破万亿，基因疗法与核药临床管线终止** [🔗阅读原文](https://news.google.com/rss/articles/CBMiV0FVX3lxTE1QM2VhZjJuY2tVQS1DRDVtbGE2UE9vanYzb2NuZ1EwcFUwaWlYbE9aeFJCZmpBUDRNQWZKZFhuM01GYjRzZ2xQeVVHVHdzWUR3Wmk4SmFuMA?oc=5)
- `[12:01]` **【AJH】CAR-T治疗血液系统恶性肿瘤疗效与安全性的系统回顾和荟萃分析-MedSci.cn** [🔗阅读原文](https://news.google.com/rss/articles/CBMibkFVX3lxTFA5R19LYzBab0JxT0lvRURXbHlZc0R3X2wtajNZZkJPbThYODU2TE0tY19ia2FOV0FUQnp2RnhSeGYzSU5yd0w5MmE1cUh0NWJqVkNXbnZQMTRGVDZGbXFOTFdqVE1QMmRLZzRLVk9n?oc=5)
